JaffeAC.Failure to thrive: current clinical concepts. Pediatr Rev. 2011;32:100-107.
2.
DanielMKleisLCemerogluAP.Etiology of failure to thrive in infants and toddlers referred to a pediatric endocrinology outpatient clinic. Clin Pediatr (Phila). 2008;47:762-765.
3.
FiciciogluCHaackKA.Failure to thrive: when to suspect inborn errors of metabolism. Pediatrics. 2009;124:972-979.
4.
SaudubrayJMSedelFWalterJH.Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis. 2006;29:261-274.
5.
SaudubrayJMBaumgartnerMWalterJ.Inborn Metabolic Diseases: Diagnosis and Treatment. Berlin, Germany: Springer-Verlag; 2016.
6.
RotigACormierVBlancheSet al. Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86:1601-1608.
7.
GoldsteinAFalkMJ.Mitochondrial DNA deletion syndromes. In: AdamMPArdingerHHPagonRA eds. GeneReviews®. Seattle, WA: University of Washington; 1993.
8.
SundKLZimmermanSLThomasCet al. Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships. Genet Med. 2013;15:70-78.
9.
AyedIBChamkhaIMkaouar-RebaiEet al. A Tunisian patient with Pearson syndrome harboring the 4.977kb common deletion associated to two novel large-scale mitochondrial deletions. Biochem Biophys Res Commun. 2011;411:381-386.
10.
TuminoMMeliCFarruggiaPet al. Clinical manifestations and management of four children with Pearson syndrome. Am J Med Genet A. 2011;155A:3063-3066.
11.
TadiottoEMainesEDeganiDBalterRBordugoACesaroS.Bone marrow features in Pearson syndrome with neonatal onset: a case report and review of the literature. Pediatr Blood Cancer. 2018;65. doi:10.1002/pbc.26939
12.
TothTBokayJSzonyiLNagyBPappZ.Detection of mtDNA deletion in Pearson syndrome by two independent PCR assays from Guthrie card. Clin Genet. 1998;53:210-213.
13.
SenecaSDe MeirleirLDe SchepperJet al. Pearson marrow pancreas syndrome: a molecular study and clinical management. Clin Genet. 1997;51:338-342.
14.
SatoTMuroyaKHanakawaJet al. Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review. Eur J Pediatr. 2015;174:1593-1602.
15.
RotigABourgeronTChretienDRustinPMunnichA.Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet. 1995;4:1327-1330.
16.
ShapiraAKonopnickiMHammad-SaiedMShabadE.Pearson disease in an infant presenting with severe hypoplastic anemia, normal pancreatic function, and progressive liver failure. J Pediatr Hematol Oncol. 2014;36:402-403.
17.
MorelASJorisNMeuliRet al. Early neurological impairment and severe anemia in a newborn with Pearson syndrome. Eur J Pediatr. 2009;168:311-315.
18.
ParkJRyuHJangWet al. Novel 5.712 kb mitochondrial DNA deletion in a patient with Pearson syndrome: a case report. Mol Med Rep. 2015;11:3741-3745.
19.
ManeaEMLevergerGBellmannFet al. Pearson syndrome in the neonatal period: two case reports and review of the literature. J Pediatr Hematol Oncol. 2009;31:947-951.
20.
LohiOKuuselaALArolaM.A novel deletion in a Pearson syndrome infant with hypospadias and cleft lip and palate. J Inherit Metab Dis. 2005;28:1165-1166.
21.
WarrisAVerweijPEBartonRCrabbeDCEvansEGMeisJF.Invasive aspergillosis in two patients with Pearson syndrome. Pediatr Infect Dis J. 1999;18:739-741.
22.
ArzanianMTEghbaliAKarimzadePAhmadiMHoushmandMRezaeiN.mtDNA deletion in an Iranian infant with Pearson marrow syndrome. Iran J Pediatr. 2010;20:107-112.
23.
FarruggiaPDi CataldoAPintoRMet al. Pearson syndrome: a retrospective cohort study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica). JIMD Rep. 2016;26:37-43.
24.
CrippaBLLeonECalhounALowichikAPasqualiMLongoN.Biochemical abnormalities in Pearson syndrome. Am J Med Genet A. 2015;167A:621-628.
25.
AtaleABonneau-AmatiPRotigAet al. Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome. Eur J Med Genet. 2009;52:23-26.
26.
LeeHFLeeHJChiCSTsaiCRChangTKWangCJ.The neurological evolution of Pearson syndrome: case report and literature review. Eur J Paediatr Neurol. 2007;11:208-214.
27.
WilliamsTBDanielsMPuthenveetilGChangRWangRYAbdenurJE.Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. Mol Genet Metab. 2012;106:104-107.
28.
BroomfieldASweeneyMGWoodwardCEet al. Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis. 2015;38:445-457.
29.
McShaneMAHammansSRSweeneyMet al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet. 1991;48:39-42.
30.
FalconCPHowardTH.An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure. Blood. 2017;129:2710.
31.
GibsonKMBennettMJMizeCEet al. 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr. 1992;121:940-942.
32.
KitanoTYoshidaS.Pearson syndrome as a rare cause of failure to thrive, anemia and exocrine pancreatic insufficiency: a case report. Pediatr Therap. 2018;8:341.
33.
MagnerMKolarovaHHonzikTŠvandováIZemanJ.Clinical manifestation of mitochondrial diseases. Dev Period Med. 2015;19:441-449.
34.
ChinneryPF.Mitochondrial disorders overview. In: AdamMPArdingerHHPagonRA eds. GeneReviews®. Seattle, WA: University of Washington; 1993.
35.
MurakiKNishimuraSGotoYNonakaISakuraNUedaK.The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis. 1997;20:697-703.
